Clinical Trial Update: Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update for a fluocinolone acetonide implant to treat refractory ocular Behçet's disease with non-infectious uveitis; current status is not disclos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis
• Ocular Behçet Disease

Drugs mentioned

• Retisert (fluocinolone acetonide)

Snippet

Sponsor: Asan Medical Center | Conditions: Ocular Behcet's Disease,, Non-Infectious Uveitis | Phase 4 | Status: UNKNOWN